Ear Care in South Korea

Table of Contents

• OTC HEALTHCARE IN SOUTH KOREA : MARKET INSIGHT
• EXECUTIVE SUMMARY
• Continued slowdown in 2008
• More OTC products are expected to switch to quasi-drugs
• Fast growth of the Rx market hinders growth of OTC healthcare
• Active movement in new product developments and the acquisition of patents
• Product margins for pharmacists affect sales of OTC products
• KEY TRENDS AND DEVELOPMENTS
• Manufacturers' efforts in research and the acquisition of patents
• Economy slowdown affects OTC healthcare in Korea
• More OTC healthcare products are expected to switch to quasi-drugs
• Distribution channels are more diverse during the review period
• Suppliers appease pharmacists with high margins
• MARKET INDICATORS
  • Table 1Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2Life Expectancy at Birth 2003-2008
• MARKET DATA
  • Table 3Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5OTC Healthcare Company Shares by Value 2004-2008
  • Table 6OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 8Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 9Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
• APPENDIX
• OTC Registration and Classification
• Vitamins & Dietary Supplements Registration and Classification
• Self-medication and Preventative Medicine
• Generics
• Switches
• DEFINITIONS
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - SOUTH KOREA
• DAEWOONG PHARMACEUTICAL CO LTD - OTC HEALTHCARE - SOUTH KOREA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
  • Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2008
• DONG WHA PHARMACEUTICAL INDUSTRIAL CO LTD - OTC HEALTHCARE - SOUTH KOREA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 6 Dong Wha Pharmaceutical Industrial Co Ltd: Key Facts
  • Summary 7 Dong Wha Pharmaceutical Industrial Co Ltd: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 8 Dong Wha Pharmaceutical Industrial Co Ltd: Production Statistics
• COMPETITIVE POSITIONING
  • Summary 9 Dong Wha Pharmaceutical Industrial Co Ltd: Competitive Position 2008
• DONG-A PHARMACEUTICAL CO LTD - OTC HEALTHCARE - SOUTH KOREA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 10 Dong-A Pharmaceutical Co Ltd: Key Facts
  • Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics
• COMPETITIVE POSITIONING
  • Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2008
• KWANG DONG PHARM CO LTD - OTC HEALTHCARE - SOUTH KOREA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 14 Kwang Dong Pharm Co Ltd: Key Facts
  • Summary 15 Kwang Dong Pharm Co Ltd: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 16 Kwang Dong Pharm Co Ltd: Production Statistics 2008
• COMPETITIVE POSITIONING
  • Summary 17 Kwang Dong Pharm Co Ltd: Competitive Position 2008
• SK CHEMICALS CO LTD - OTC HEALTHCARE - SOUTH KOREA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 18 SK Chemicals Co Ltd: Key Facts
  • Summary 19 SK Chemicals Co Ltd: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 20 SK Chemicals Co Ltd: Production Statistics
• COMPETITIVE POSITIONING
  • Summary 21 SK Chemical Co Ltd: Competitive Position 2008
• EAR CARE IN SOUTH KOREA
• HEADLINES